Phase 2 Relapsing Multiple Sclerosis trials recruiting now

All Relapsing Multiple Sclerosis trials, every phase

Other phases for Relapsing Multiple Sclerosis

Phase 2 Relapsing Multiple Sclerosis trials

• A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
  NCT07161258 · Phase: Phase 2 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 17 locations
• An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
  NCT06617793 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 18 locations
• Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
  NCT07220252 · Phase: Phase 2, Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 2 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.